Health Business Group
JANUARY 4, 2024
Nole , as she shares her progression from first-generation college graduate to Corporate Vice President of Microsoft Health & Life Sciences and General Manager of the Nuance Healthcare Division. Join me for a great discussion with Diana L.
HIT Consultant
FEBRUARY 13, 2024
Brian Williams, Life Sciences Strategy & Innovation at EPAM Systems, Inc. Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
MARCH 29, 2022
What You Should Know: – ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B Accelerating Enterprise SaaS AI from Clinical Research to Clinical Practice.
HIT Consultant
MARCH 4, 2024
What You Should Know: ArteraAI , a leader in artificial intelligence (AI)-powered cancer tests, today announced a significant achievement – the inclusion of their ArteraAI Prostate Test in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer.
Healthcare It News
FEBRUARY 26, 2024
Somai knows AI, and strongly believes it is an integral part of the healthcare ecosystem and poised to bring about powerful, transformative change to the industry. By integrating genAI into the fabric of healthcare, we stand really on the brink of a new frontier in medicine and life sciences.
Health Business Group
DECEMBER 11, 2023
Syntropy’s product development team leader, Michael Vande-Vrede answered my questions about what it all means in practice. What are the key data quality challenges in clinical research and clinical practice? Collectively, we cover the complete spectrum of the data lifecycle, enhancing data integrity at every phase.
HIT Consultant
MARCH 24, 2023
Racism in R&D/Clinical practices: Lack of representation of people of color (POC) among both patients and physicians, barriers to access and other obstacles like bias, lack of trust and fear, and limited care access all limit the quality of health and research outcomes among affected groups. SCAN Health Plan) 4.
Expert insights. Personalized for you.
52 
Let's personalize your content